HK Stock Market Move | BIODLINK-B (01875) resumes trading with a more than 58% opening increase, with WUXI XDC offering a cash tender offer at a premium of approximately 99%.
Dongyang Pharmaceutical-B (01875) opened significantly higher after resumption of trading, rising by 58.8% to HK$3.97 as of the time of writing, with a turnover of HK$1.1211 million.
After resumption of trading, BIODLINK-B (01875) opened significantly higher, up 58.8% to HKD 3.97 as of the time of writing, with a trading volume of HKD 1.1211 million.
On the news front, Dongyao Pharmaceutical and WUXI XDC (02268) jointly announced that WUXI XDC has proposed a voluntary offer to acquire all shares of Dongyao Pharmaceutical at a cash price of HKD 4 per share, representing a premium of approximately 99.00% over the closing price of HKD 2.01 per share before the trading halt. The maximum consideration of the offer is approximately HKD 2.79 billion. The offeror intends to maintain the listing of the shares on the Stock Exchange upon completion.
Related Articles
HK Stock Market Move | HAICHANG HLDG(02255) rose more than 20% in early trading. On the first day of Shanghai HAICHANG HLDG New Year holiday, visitor traffic increased by 60% year-on-year.
HK Stock Market Move | KNOWLEDGE ATLAS (02513) rises more than 6% against the market trend, recently announced a partnership with Huawei to open-source a new generation image generating model.
Morgan Stanley CIO Survey: Enterprise Software budget to accelerate by 2026, Microsoft Corporation (MSFT.US) leads in Generative AI spending with a 34% share.
HK Stock Market Move | HAICHANG HLDG(02255) rose more than 20% in early trading. On the first day of Shanghai HAICHANG HLDG New Year holiday, visitor traffic increased by 60% year-on-year.
HK Stock Market Move | KNOWLEDGE ATLAS (02513) rises more than 6% against the market trend, recently announced a partnership with Huawei to open-source a new generation image generating model.
Morgan Stanley CIO Survey: Enterprise Software budget to accelerate by 2026, Microsoft Corporation (MSFT.US) leads in Generative AI spending with a 34% share.
